148 related articles for article (PubMed ID: 33862495)
41. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
42. Discovery of (2-fluoro-benzyl)-(2-methyl-2-phenethyl-2H-chromen-6-yl)-amine (KRH-102140) as an orally active 5-lipoxygenase inhibitor with activity in murine inflammation models.
Cho YS; Song JS; Huh JY; Kim CH; Gong YD; Cheon HG
Pharmacology; 2011; 87(1-2):49-55. PubMed ID: 21212714
[TBL] [Abstract][Full Text] [Related]
43. CD226 deletion improves post-infarction healing via modulating macrophage polarization in mice.
Li J; Song Y; Jin JY; Li GH; Guo YZ; Yi HY; Zhang JR; Lu YJ; Zhang JL; Li CY; Gao C; Yang L; Fu F; Chen FL; Zhang SM; Jia M; Zheng GX; Pei JM; Chen LH
Theranostics; 2020; 10(5):2422-2435. PubMed ID: 32104514
[TBL] [Abstract][Full Text] [Related]
44. Ginsenoside Rd Promotes Cardiac Repair After Myocardial Infarction by Modulating Monocytes/Macrophages Subsets Conversion.
Zhao T; Wang X; Liu Q; Yang T; Qu H; Zhou H
Drug Des Devel Ther; 2022; 16():2767-2782. PubMed ID: 36033133
[TBL] [Abstract][Full Text] [Related]
45. A rat air pouch model for evaluating the efficacy and selectivity of 5-lipoxygenase inhibitors.
Zweifel BS; Hardy MM; Anderson GD; Dufield DR; Pufahl RA; Masferrer JL
Eur J Pharmacol; 2008 Apr; 584(1):166-74. PubMed ID: 18295198
[TBL] [Abstract][Full Text] [Related]
46. Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice.
Adamek A; Jung S; Dienesch C; Laser M; Ertl G; Bauersachs J; Frantz S
Eur J Pharmacol; 2007 Sep; 571(1):51-4. PubMed ID: 17586489
[TBL] [Abstract][Full Text] [Related]
47. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
48. Splenic leukocytes define the resolution of inflammation in heart failure.
Halade GV; Norris PC; Kain V; Serhan CN; Ingle KA
Sci Signal; 2018 Mar; 11(520):. PubMed ID: 29511119
[TBL] [Abstract][Full Text] [Related]
49. 15-Lipoxygenases regulate the production of chemokines in human lung macrophages.
Abrial C; Grassin-Delyle S; Salvator H; Brollo M; Naline E; Devillier P
Br J Pharmacol; 2015 Sep; 172(17):4319-30. PubMed ID: 26040494
[TBL] [Abstract][Full Text] [Related]
50. HDAC inhibition helps post-MI healing by modulating macrophage polarization.
Kimbrough D; Wang SH; Wright LH; Mani SK; Kasiganesan H; LaRue AC; Cheng Q; Nadig SN; Atkinson C; Menick DR
J Mol Cell Cardiol; 2018 Jun; 119():51-63. PubMed ID: 29680681
[TBL] [Abstract][Full Text] [Related]
51. Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
Yamazaki R; Aiyama R; Matsuzaki T; Hashimoto S; Yokokura T
Inflamm Res; 1998 Apr; 47(4):182-6. PubMed ID: 9628261
[TBL] [Abstract][Full Text] [Related]
52. S100A9 Links Inflammation and Repair in Myocardial Infarction.
Marinković G; Koenis DS; de Camp L; Jablonowski R; Graber N; de Waard V; de Vries CJ; Goncalves I; Nilsson J; Jovinge S; Schiopu A
Circ Res; 2020 Aug; 127(5):664-676. PubMed ID: 32434457
[TBL] [Abstract][Full Text] [Related]
53. Licofelone, a dual cyclooxygenase/5-lipoxygenase inhibitor, reverses endotoxin-induced impaired atrial chronotropic responsiveness to cholinergic stimulation in rats.
Nikoui V; Mehrzadi S; Khan MI; Aman W; Ostadhadi S; Dehpour AR
Eur J Pharmacol; 2020 Nov; 887():173569. PubMed ID: 32949599
[TBL] [Abstract][Full Text] [Related]
54. Anti-inflammatory celastrol promotes a switch from leukotriene biosynthesis to formation of specialized pro-resolving lipid mediators.
Pace S; Zhang K; Jordan PM; Bilancia R; Wang W; Börner F; Hofstetter RK; Potenza M; Kretzer C; Gerstmeier J; Fischer D; Lorkowski S; Gilbert NC; Newcomer ME; Rossi A; Chen X; Werz O
Pharmacol Res; 2021 May; 167():105556. PubMed ID: 33812006
[TBL] [Abstract][Full Text] [Related]
55. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.
Qian C; Hwang SB; Libertine-Garahan L; Eckman JB; Cai X; Scannell RT; Yeh CG
Pharmacol Res; 2001 Sep; 44(3):213-20. PubMed ID: 11529688
[TBL] [Abstract][Full Text] [Related]
56. 5-Lipoxygenase facilitates healing after myocardial infarction.
Blömer N; Pachel C; Hofmann U; Nordbeck P; Bauer W; Mathes D; Frey A; Bayer B; Vogel B; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2013 Jul; 108(4):367. PubMed ID: 23812248
[TBL] [Abstract][Full Text] [Related]
57. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-4 and -13 induce upregulation of the murine macrophage 12/15-lipoxygenase activity: evidence for the involvement of transcription factor STAT6.
Heydeck D; Thomas L; Schnurr K; Trebus F; Thierfelder WE; Ihle JN; Kühn H
Blood; 1998 Oct; 92(7):2503-10. PubMed ID: 9746791
[TBL] [Abstract][Full Text] [Related]
59. Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels.
Petrera A; Gassenhuber J; Ruf S; Gunasekaran D; Esser J; Shahinian JH; Hübschle T; Rütten H; Sadowski T; Schilling O
J Transl Med; 2016 May; 14(1):153. PubMed ID: 27246731
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
